Strahlentherapie und Onkologie

Papers
(The TQCC of Strahlentherapie und Onkologie is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Radiomics and deep learning in lung cancer127
Applications of radiomics and machine learning for radiotherapy of malignant brain tumors75
Radiomics in radiation oncology—basics, methods, and limitations48
Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward37
Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?36
Radiomic biomarkers for head and neck squamous cell carcinoma30
Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)28
Quality of life and fatigue before and after radiotherapy in breast cancer patients26
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial26
The role of radiomics in prostate cancer radiotherapy24
Role of cancer stem cell markers ALDH1, BCL11B, BMI-1, and CD44 in the prognosis of advanced HNSCC24
Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID t23
Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy23
Quality of teaching radiation oncology in Germany—where do we stand?22
Ultrahypofractionation of localized prostate cancer22
Low-dose radiotherapy for COVID-19 pneumonia treatment: case report, procedure, and literature review21
Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial—PaCa-DD-041 (Eudra-CT 2009-01196820
COVID-19 pneumonia treated with ultra-low doses of radiotherapy (ULTRA-COVID study): a single institution report of two cases20
Impact of intracavitary brachytherapy technique (2D versus 3D) on outcomes of cervical cancer: a systematic review and meta-analysis19
Intraoperative radiotherapy with low-energy x-rays after neurosurgical resection of brain metastases—an Augsburg University Medical Center experience18
Dental extraction, intensity-modulated radiotherapy of head and neck cancer, and osteoradionecrosis17
Cone-beam computed tomography-based radiomics in prostate cancer: a mono-institutional study17
Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer17
Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial17
Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users17
The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry16
Effectiveness of rectal displacement devices in managing prostate motion: a systematic review16
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma15
Computed tomography-based deep-learning prediction of induction chemotherapy treatment response in locally advanced nasopharyngeal carcinoma15
miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis15
Is prone free breathing better than supine deep inspiration breath-hold for left whole-breast radiotherapy? A dosimetric analysis15
Improving dose delivery accuracy with EPID in vivo dosimetry: results from a multicenter study15
Radiation oncology as part of medical education—current status and possible digital future prospects14
Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study14
Managing patient flows in radiation oncology during the COVID-19 pandemic14
Value of PET imaging for radiation therapy13
Focused ultrasound radiosensitizes human cancer cells by enhancement of DNA damage13
Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy13
Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center—a single-center experience13
Anxiety and depression in patients with breast cancer undergoing radiotherapy: the role of intelligence, life history, and social support—preliminary results from a monocentric analysis13
Impact of guideline changes on adoption of hypofractionation and breast cancer patient characteristics in the randomized controlled HYPOSIB trial12
Impact of radiation techniques on lung toxicity in patients with mediastinal Hodgkin’s lymphoma12
Early morbidity and dose–volume effects in definitive radiochemotherapy for locally advanced cervical cancer: a prospective cohort study covering modern treatment techniques11
Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective11
Simultaneous stereotactic radiosurgery of multiple brain metastases using single-isocenter dynamic conformal arc therapy: a prospective monocentric registry trial11
Radiotherapy in nodal oligorecurrent prostate cancer11
Implementation of a dedicated 1.5 T MR scanner for radiotherapy treatment planning featuring a novel high-channel coil setup for brain imaging in treatment position11
Risk assessment, surveillance, and nonpharmaceutical prevention of acute radiation dermatitis: results of a multicentric survey among the German-speaking radiation oncology community11
Intraoperative radiotherapy boost as part of breast-conservation therapy for breast cancer: a single-institution retrospective analysis11
Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic11
Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external11
Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations10
Parotid sparing and quality of life in long-term survivors of locally advanced head and neck cancer after intensity-modulated radiation therapy10
Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patient- and treatment-re10
Hybrid volumetric modulated arc therapy for hypofractionated radiotherapy of breast cancer: a treatment planning study10
New clinical data on human spinal cord re-irradiation tolerance10
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro10
The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review10
Head and neck tumor cells treated with hypofractionated irradiation die via apoptosis and are better taken up by M1-like macrophages10
Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach10
DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis10
Adjuvant chemoradiotherapy in elderly patients with head and neck cancer: a monoinstitutional, two-to-one pair-matching analysis10
Risk of coronary stenosis after adjuvant radiotherapy for breast cancer9
Incidental axillary dose delivery to axillary lymph node levels I–III by different techniques of whole-breast irradiation: a systematic literature review9
Implementing a new scale for failure mode and effects analysis (FMEA) for risk analysis in a radiation oncology department9
Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy9
Measures of infection prevention and incidence of SARS-CoV-2 infections in cancer patients undergoing radiotherapy in Germany, Austria and Switzerland9
Total body irradiation as part of conditioning regimens in childhood leukemia—long-term outcome, toxicity, and secondary malignancies9
Treatment of low-risk prostate cancer: a retrospective study with 477 patients comparing external beam radiotherapy and I-125 seeds brachytherapy in terms of biochemical control and late side effects9
Dose–volume parameters of MRI-based active bone marrow predict hematologic toxicity of chemoradiotherapy for rectal cancer9
Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area9
Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma—a review9
EPAS1 promotes peritoneal carcinomatosis of non-small-cell lung cancer by enhancing mesothelial–mesenchymal transition9
Digital transfer in radiation oncology education for medical students—single-center data and systemic review of the literature9
The role of a knowledge based dose–volume histogram predictive model in the optimisation of intensity-modulated proton plans for hepatocellular carcinoma patients8
Cardiac doses of accelerated partial breast irradiation with perioperative multicatheter interstitial brachytherapy8
Incorporating dose–volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated r8
Artificial intelligence and radiomics for radiation oncology8
DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment8
Efficacy of repeated PSMA PET-directed radiotherapy for oligorecurrent prostate cancer after initial curative therapy8
Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)8
Optimization of hippocampus sparing during whole brain radiation therapy with simultaneous integrated boost—tutorial and efficacy of complete directional hippocampal blocking8
Comparison of volumetric modulated arc therapy and intensity-modulated radiotherapy for left-sided whole-breast irradiation using automated planning8
Stereotactic body radiotherapy of lymph node metastases under MR-guidance: First clinical results and patient-reported outcomes8
Oncological outcome and recurrence pattern analysis after involved-field irradiation in combination with rituximab for early-stage nodal and extranodal follicular lymphoma8
Prerequisites for the clinical implementation of a markerless SGRT-only workflow for the treatment of breast cancer patients8
Low-dose radiotherapy for SARS-CoV-2 pneumonia8
Shift of radiotherapy use during the first wave of the COVID-19 pandemic? An analysis of German inpatient data8
Moderately hypofractionated radiotherapy for localized prostate cancer: updated long-term outcome and toxicity analysis8
First clinical experience with a novel, mobile cone-beam CT system for treatment quality assurance in brachytherapy8
Influence of chemoradiation on the immune microenvironment of cervical cancer patients8
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer—results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial G8
Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis—a safety analysis and validation of the EANO-ESMO classification7
Innovative radiation oncology Together – Precise, Personalized, Human7
Risk of radiation necrosis after stereotactic radiosurgery for melanoma brain metastasis by anatomical location7
Evaluation of automatic VMAT plans in locally advanced nasopharyngeal carcinoma7
Neoadjuvant concurrent chemoradiotherapy with and without hyperthermia in retroperitoneal sarcomas: feasibility, efficacy, toxicity, and long-term outcome7
Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients7
Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy7
Students’ learning behavior in digital education for radiation oncology7
Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients—sequentially, or better simultaneously?7
Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer7
Effective method to reduce the normal brain dose in single-isocenter hypofractionated stereotactic radiotherapy for multiple brain metastases7
Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer7
Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy7
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose7
Tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts7
Peer review analysis in the field of radiation oncology: results from a web-based survey of the Young DEGRO working group7
Total body irradiation of bone marrow transplant using helical TomoTherapy with a focus on the quality of dose contribution at junction target volumes7
Performance assessment of two motion management systems for frameless stereotactic radiosurgery7
Indications of IMRT, PRT and CIRT for HCC from comparisons of dosimetry and normal tissue complication possibility7
Moderate hypofractionated radiotherapy for post-operative treatment of prostate cancer: long-term outcome and pattern of toxicity7
Systematic risk analysis of radiation pneumonitis in breast cancer: role of cotreatment with chemo-, endocrine, and targeted therapy7
Radiation-induced DNA double-strand breaks in peripheral leukocytes and therapeutic response of heel spur patients treated by orthovoltage X-rays or a linear accelerator6
The brave new world of endometrial cancer6
A randomized in vitro evaluation of transient and permanent cardiac implantable electronic device malfunctions following direct exposure up to 10 Gy6
Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers6
Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients6
Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice6
Comparison of carbon ion and photon reirradiation for recurrent glioblastoma6
miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN16
Cumulative dose, toxicity, and outcomes of spinal metastases re-irradiation6
Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy6
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy6
Low-dose radiotherapy for painful osteoarthritis of the elderly: A multicenter analysis of 970 patients with 1185 treated sites6
Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer6
Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil6
Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer6
Long-term results of robotic radiosurgery for non brachytherapy patients with cervical cancer6
Impact of a ketogenic diet intervention during radiotherapy on body composition: V. Final results of the KETOCOMP study for head and neck cancer patients6
Impact of 18F-FDG-PET/CT on the identification of regional lymph node metastases and delineation of the primary tumor in esophageal squamous cell carcinoma patients6
Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 20046
Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy6
Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients—comparative analysis5
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review5
Treatment outcomes of MRI-guided adaptive brachytherapy in patients with locally advanced cervical cancer: institutional experiences5
Teaching in radiation oncology: now and 2025—results of a focus group with medical students5
The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy5
Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer5
Development, implementation, and results of a simulation-based hands-on brachytherapy workshop for medical students5
The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists5
Evaluation of the ability of the Brainlab Elements Cranial Distortion Correction algorithm to correct clinically relevant MRI distortions for cranial SRT5
Long-term results of radio(chemo)therapy in metastatic carcinoma to cervical lymph nodes from an unknown primary. Adult Comorbidity Evaluation 27 score as a predictor of survival5
MicroRNA-29b regulates the radiosensitivity of esophageal squamous cell carcinoma by regulating the BTG2-mediated cell cycle5
PSMA-PET-CT zum primären Staging von Patienten mit fortgeschrittenem Prostatakarzinom5
Role of palliative SBRT in barcelona clinic liver cancer-stage C hepatocellular carcinoma patients5
Synergistic effect of PAF inhibition and X-ray irradiation in non-small cell lung cancer cells5
Patterns of care for prostate cancer radiotherapy—results from a survey among German-speaking radiation oncologists5
#Stayathome: Smart working for radiation oncologists during the corona pandemic5
Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiatio5
Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases5
Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial5
Radiotherapy of the oldest old—feasibility and institutional analysis5
Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients5
Assessment of intrafractional prostate motion and its dosimetric impact in MRI-guided online adaptive radiotherapy with gating5
Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer5
Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies5
Bone-only oligometastatic renal cell carcinoma patients treated with stereotactic body radiotherapy: a multi-institutional study5
0.062190055847168